Co-Authors
This is a "connection" page, showing publications co-authored by Mark Mulligan and Amit Saxena.
Connection Strength
0.123
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
Score: 0.062
-
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19. Clin Pharmacol Ther. 2021 12; 110(6):1467-1477.
Score: 0.061